Brief: Ocular Therapeutix reports inducement grants under Nasdaq listing rule 5635(C)(4)
08/05/2026 21:20
May 8 (Reuters) - Ocular Therapeutix Inc OCUL.O: OCULAR THERAPEUTIX™ REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNXbY8H0z Further company coverage: OCUL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocular Therapeutix
See all newsBrief: Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
EyePoint's late-stage eye drug trials to continue after safety panel review (updated)
EyePoint's late-stage eye drug trials to continue after safety panel review
Brief: Ocular Therapeutix reports inducement grants under Nasdaq listing rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune